Lacosphere - 13C,solution D3, 100 mug / mL en acétonitrile, ampule de 1 mL, matériau de référence certifié

Code: L-027-1ML D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The dru...


 En savoir plus

Votre prix
$215.93 1ML
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat®. This internal standard is suitable for lacosamide testing methods by LC/MS or GC/MS for clinical toxicology, forensic analysis, or urine drug testing.

Legal Information

Snap-N-Spike is a registered trademark of Cerilliant Corporation

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

CERILLIANT is a registered trademark of Cerilliant Corporation

Vimpat is a registered trademark of Harris FRC Corporation

application(s)clinical testing
concentration100 µg/mL in acetonitrile
featureSnap-N-Spike®/Snap-N-Shoot®
formliquid
formatsingle component solution
gradecertified reference material
InChI keyVPPJLAIAVCUEMN-RUXIMPAMSA-N
InChI1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1/i2+1D3
manufacturer/tradenameCerilliant®
packagingampule of 1 mL
Quality Level300
SMILES string[2H][13C]([2H])([2H])OC[C@@H](NC(C)=O)C(=O)NCc1ccccc1
storage temp.−20°C
technique(s)gas chromatography (GC): suitable, liquid chromatography (LC): suitable
Hazard Class3
Un Number1648
Pack Group2
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.